PRAXIS PRECISION MEDICINES, INC. Variable Lease, Cost
PRAXIS PRECISION MEDICINES, INC. (PRAX) reported Variable Lease, Cost of $51.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-02-19
- PRAXIS PRECISION MEDICINES, INC. variable lease, cost for fiscal 2025 was $51.00K, a 54.55% increase from fiscal 2024.
- PRAXIS PRECISION MEDICINES, INC. variable lease, cost for fiscal 2024 was $33.00K, a 135.71% increase from fiscal 2023.
- PRAXIS PRECISION MEDICINES, INC. variable lease, cost for fiscal 2023 was $14.00K, a 62.16% decline from fiscal 2022.
- PRAXIS PRECISION MEDICINES, INC. variable lease, cost for fiscal 2022 was $37.00K, a 8.82% increase from fiscal 2021.
| Period end | Variable Lease, Cost 12 month |
|---|---|
| 2025-12-31 | $51.00K 10-K · filed 2026-02-19 |
| 2024-12-31 | $33.00K 10-K · filed 2026-02-19 |
| 2023-12-31 | $14.00K 10-K · filed 2026-02-19 |
| 2022-12-31 | $37.00K 10-K · filed 2024-03-05 |
| 2021-12-31 | $34.00K 10-K · filed 2023-02-07 |
| 2020-12-31 | $14.00K 10-K · filed 2022-02-28 |
| 2019-12-31 | $3.00K 10-K · filed 2021-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |